HASSAN, M. S.; JAWAD, A. M. Assessment of Pathological Response to Neoadjuvant Therapy: Comparison Between Pertuzumab-Based and Non-Pertuzumab Protocols in HER2-Positive Breast Cancer. Middle Eastern Cancer and Oncology Journal, v. 2, n. 3, p. 1–9, 12 Jul.2026.